Latest Merck Analyte Update Now Available!
Your latest comprehensive guide to multiplex and Single Protein Detection assays is now available!
05Mar
News
06Nov
Buy 2 MILLIPLEX Kits and Get the 3rd FREE
NEW ZEALAND OFFER – For the month of November only, buy 2 MILLIPLEX Kits and receive the 3rd FREE.
02Oct
NEW Merck MILLIPLEX® MAP Human Cancer Autoantibody Panel
New Merck MILLIPLEX® MAP Human Cancer Autoantibody Panel, a 15-plex customisable panel.
30Sep
Buy 2 MILLIPLEX Kits and Get the 3rd FREE
For the month of October only, buy 2 MILLIPLEX Kits and receive the 3rd FREE.
18Sep
Launch of the Idylla™ ctNRAS-BRAF-EGFR S492R Mutation Assay (Research Use Only)
Being the third¹ liquid biopsy test for Biocartis, the newly launched assay, Idylla™ ctNRAS-BRAF-EGFR S492R Mutation Assay (Research Use Only), also marks an important milestone in the partnership with the leading science and technology company Merck².
18Sep
Biocartis launches second liquid biopsy assay
Biocartis, an innovative molecular diagnostics company, today announces the launch of its second liquid biopsy assay, the Idylla™ ctKRAS Mutation Assay (Research Use Only, RUO), which was developed in partnership with the leading science and technology company Merck1 on Biocartis’ molecular diagnostics platform Idylla™.
13Jun
Latest Merck Analyte Update Now Available!
Your latest comprehensive guide to multiplex and single protein detection assays is now available!
29May
Introducing the SMCxPRO
Introducing the SMCxPRO – sensitivity you can count on!
19Feb
Webinar: Multiplex assays of the anti-apoptotic BCL-2 family
Multiplex assays of the anti-apoptotic BCL-2 family
A hallmark of cancer cells is defects in the apoptotic cell death program.